Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Medtronic (MDT)

Medtronic FY26 revenue rises 8.4% to $36.4 billion; FY27 EPS guidance $5.90-$6.00

Positive Impact 3 of 5 earnings Written later

Medtronic reported fiscal 2026 revenue of $36.4 billion, up 8.4% as reported and 5.8% organic, and fourth-quarter revenue of $9.8 billion, up 9.9%. Fiscal 2026 non-GAAP diluted EPS rose 0.7% to $5.53, while non-GAAP operating margin fell 130 basis points, and fourth-quarter non-GAAP diluted EPS fell 4.3% to $1.55. The company guided fiscal 2027 non-GAAP diluted EPS to $5.90 to $6.00 and raised its quarterly dividend to $0.72 per share.

Key points

  • Q4 revenue was $9.807 billion, up 9.9% as reported and 6.6% organic.
  • Q4 GAAP diluted EPS was $0.96, up 17.1%; non-GAAP diluted EPS was $1.55, down 4.3%.
  • FY27 guidance calls for organic revenue growth of 6.75% to 7.25% and non-GAAP diluted EPS of $5.90 to $6.00.
  • Quarterly dividend raised to $0.72 per share, payable July 17, 2026, to holders of record on June 26, 2026.

The filing

CompanyMedtronic (MDT)
Form8-K, current report
Filed with the SECJun 3, 2026, 6:47 AM ET
Accession number0001628280-26-040034

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 2:16 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 03, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.